Manager, Global Trade Operations, Cell Therapy in Devens, MA at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

Expertise in US Federal guidelines and regulations related to export controls, denied parties, and embargoed countries
Knowledge of global export compliance in countries where BMS is an exporter
Familiarity with export transactions including proper invoice practices, ECCN/Licensing Requirements, denied parties, and embargoed countries
Experience with Restricted Party Screening processes within SAP and other third-party programs
Ability to draft, organize, and manage US Export licenses
Commitment to excellence, integrity, ownership, and accountability for results
Subject matter expertise on Site Import Administration related activities, issues, and questions

Responsibilities

Ensure import and export compliance for BMS North American operations, including compliance with US Federal guidelines
Assist with global export compliance in countries where BMS is an exporter
Provide support for export transactions escalated to the Corporate Customs & Trade Compliance organization
Support management of Restricted Party Screening processes within SAP and other third-party programs
Support drafting, organization, and management of US Export licenses
Execute international shipments between sites across the Cell Therapy network, including customs operations management and automation, stakeholder communication, and managing through final delivery
Manage and maintain files of all inbound and outbound customs and trade documentation in audit-ready state; coordinate with internal customers for audits or information requests pertaining to FTZ, TIB, and Standard entry summary 7501
Adhere to applicable processes and work instructions for alignment with global and site policies and procedures
Support Cell Therapy trade operations and logistics management team on customs and trade compliance processes and productivity improvement initiatives
Execute Site Import and Export Administration responsibilities for FTZ
Facilitate communication with customs brokers to ensure accurate documentation for timely BMS imports with minimum delays and zero errors
Provide clearance information to designated brokers, FDA, and other government agencies for entries
Relay release information to operations to prevent manipulation or disbursement of inbound shipments prior to FDA Release, as applicable
Maintain and automate an Import Checklist to ensure all entries are properly submitted

Skills

Global Trade Compliance

Export Controls

Import Compliance

US Federal Regulations

Denied Parties Screening

Embargoed Countries

ECCN

Licensing Requirements

Customs Compliance

Invoice Practices

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free